Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 117.56M P/E - EPS this Y -37.10% Ern Qtrly Grth -
Income -125.33M Forward P/E -0.93 EPS next Y 15.30% 50D Avg Chg -10.00%
Sales 12.42M PEG -0.03 EPS past 5Y - 200D Avg Chg -74.00%
Dividend N/A Price/Book 1.00 EPS next 5Y 30.00% 52W High Chg -88.00%
Recommedations 2.20 Quick Ratio 2.97 Shares Outstanding 103.12M 52W Low Chg 13.00%
Insider Own 1.69% ROA -36.00% Shares Float 76.13M Beta 1.82
Inst Own 84.60% ROE -94.98% Shares Shorted/Prior 6.49M/7.88M Price 1.14
Gross Margin - Profit Margin - Avg. Volume 6,930,116 Target Price 6.00
Oper. Margin -979.63% Earnings Date Nov 3 Volume 2,443,655 Change -0.87%
Ardelyx, Inc. News
09:49 AM Hedge Funds Are Coming Back To Ardelyx Inc (ARDX)
10/13/21 East Bay drug maker lays off 102 more people after FDA rejection
10/13/21 Ardelyx Provides Corporate Update Following Type A Meeting with FDA
09/30/21 Kessler Topaz Meltzer & Check, LLP:  Important Deadline Reminder for Ardelyx Inc. Investors in Securities Fraud Class Action Lawsuit
09/29/21 Final Deadline Approaching on October 4, 2021: Kessler Topaz Meltzer & Check, LLP Reminds Ardelyx Inc. Investors of Class Action Lawsuit Deadline
09/28/21 SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Ardelyx, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 28, 2021 - ARDX
09/28/21 ARDX Final Deadline Today: Rosen, National Trial Lawyers, Encourages Ardelyx, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important September 28 Deadline in Securities Class Action - ARDX
09/28/21 CLASS ACTION UPDATE for ARDX, ANVS and SAVA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
09/28/21 Ardelyx Inc. Class Action Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of Deadline in Securities Fraud Class Action Lawsuit
09/28/21 DEADLINE TODAY: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ardelyx, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
09/28/21 SHAREHOLDER ALERT: ARDX LIVE SPPI: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
08:15 PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ardelyx, SelectQuote, Katapult, and Waterdrop Sciences and Encourages Investors to Contact the Firm
07:45 PM SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ardelyx, Inc. of Class Action Lawsuit and Upcoming Deadline - ARDX
11:10 AM LAWSUITS FILED AGAINST ARDX, HYRE and WDH - Jakubowitz Law Pursues Shareholders Claims
09:53 AM ARDX Final Deadline Tomorrow: Rosen, a Leading Investor Rights Law Firm, Encourages Ardelyx, Inc. Investors with Losses to Secure Counsel Before Important September 28 Deadline in Securities Class Action - ARDX
09:00 AM The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ARDX, ANVS and VIEW
09:00 AM Last Few Hours to Actively Participate in Ardelyx, Inc. (ARDX) Class Action: Bronstein, Gewirtz & Grossman, LLC
07:30 AM DEADLINE TOMORROW: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ardelyx, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
09/26/21 ARDX FINAL DEADLINE TUESDAY: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Ardelyx, Inc. Investors with Losses to Secure Counsel Before Important September 28 Deadline in Securities Class Action – ARDX

Ardelyx, Inc., a biopharmaceutical company, develops and sells medicines for the treatment of kidney and cardiorenal diseases in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase 3 clinical trial for the treatment of patients with irritable bowel syndrome with constipation, as well as in Phase 3 clinical trial for the treatment of hyperphosphatemia in end-stage renal disease patients on dialysis. It also develops RDX013, a small molecule potassium secretagogue program that is in Phase 2 clinical trial for the treatment of patients with hyperkalemia; and RDX020, a small molecule program for the treatment of metabolic acidosis. The company was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. Ardelyx, Inc. was incorporated in 2007 and is headquartered in Fremont, California.

ARDX Chatroom

User Image SmallCapManager Posted - 1 hour ago

$CRTX This will go below $10/share soon. If you’re thinking that just because something dropped 75% that it’s immediately a good deal, why don’t you talk to the people over at $ARDX after their initial 75% drop. See how they are doing at another 50% drop after that from $2 to $1/share, originally being around $8/share. Tread carefully everyone, it’s cash burn rate is too high and it’s current prospects are dim.

User Image georgeyann Posted - 6 hours ago

$ARDX now I have 10k shares! May add 20k shares more! See you $3 soon

User Image avio Posted - 7 hours ago

$ARDX 🥱🥱🥱🥱🥱

User Image radiostock Posted - 7 hours ago

$ARDX A slide from one of their presentation I found!. Hoe much time, efforts and money it took to come to this stage.

User Image Sanmeet0512 Posted - 7 hours ago

$ARDX https://www.google.com/amp/s/finance.yahoo.com/amphtml/news/hedge-funds-coming-back-ardelyx-144906288.html

User Image Goosebumpsx Posted - 7 hours ago

$ARDX we’re going to be asked for a new trial in the minutes as previously alluded too by the CRL ,IMO an appeal is the best response if management truly have confidence in the data , more-so if there isn’t anything hidden . and without safety concerns approval is very much a possibility , an appeal alone should skyrocket the ticker to 2-4 dollar range , anything short of an appeal would be difficult to stomach in the short term .

User Image apes09 Posted - 8 hours ago

$ARDX I bought it for the first time today. $1.14! I'll pray every day.

User Image Garbagamous Posted - 9 hours ago

$ARDX

User Image Adal777 Posted - 9 hours ago

$ARDX Whens the news?

User Image lyn30 Posted - 9 hours ago

$ARDX Approve and finish the game Let’s make some good chunk 💰 💰

User Image georgeyann Posted - 9 hours ago

$ARDX buy it NOW! Thank me later

User Image georgeyann Posted - 9 hours ago

$ARDX collaborator from China has provided “substantial evidence that tenapanor is effective “

User Image georgeyann Posted - 9 hours ago

$ARDX be prepared $3 this week,

User Image Sporked Posted - 10 hours ago

$ARDX News today AH please?

User Image georgeyann Posted - 10 hours ago

$ARDX bought 7000 shares $1.15! Something big ……

User Image OldManLogan Posted - 11 hours ago

$ARDX Geez, it must take a lot of effort to keep us pinned exactly between $1.16 and $1.17...

User Image Assyrian123 Posted - 11 hours ago

$ARDX

User Image Waylon1 Posted - 12 hours ago

$ARDX 2+ next PR

User Image SqueezePlease Posted - 13 hours ago

$ARDX

User Image ShaunG91 Posted - 13 hours ago

$ARDX the only green in a sea of red in my portfolio fuck is this what its come too 😅

User Image wowfactor Posted - 13 hours ago

$ARDX just added 5000 @1.16 as well

User Image OldManLogan Posted - 13 hours ago

$ARDX I YOLO'd and added 10K at $1.15 today... got my average under $2 now...

User Image CorruptGov Posted - 13 hours ago

$ARDX just fyi don’t buy a halt. I’m at an additional -7k loss down -400%. I pick the worst stocks imaginable along with this one for months. I really don’t have this type of $ to be playing with these huge losses. Who knew

User Image Sanmeet0512 Posted - 13 hours ago

$ARDX

User Image Computer5050 Posted - 13 hours ago

$ARDX

User Image lyn30 Posted - 14 hours ago

$ARDX

User Image Danny19721972 Posted - 15 hours ago

$ARDX Exciting days ahead! Type A min can come anytime. New trial or more likely Appeal for reversal. NORMALIZE complete data release will be supportive. Cashburn already down and ATM handy. Lenders may get convinced by health of the company.

User Image Salvacrispo Posted - 15 hours ago

$ARDX $4 coming

User Image ShaunG91 Posted - 15 hours ago

$ARDX got the minutes yet?

User Image RaisinBrain Posted - 16 hours ago

$ARDX type a where ya at

Analyst Ratings
Ladenburg Thalmann Neutral Oct 14, 21
Ladenburg Thalmann Hold Oct 14, 21
Jefferies Hold Jul 21, 21
Wedbush Neutral Jul 20, 21
Piper Sandler Neutral Jul 20, 21
Wedbush Outperform Mar 23, 21
Cantor Fitzgerald Overweight Jan 6, 21
SVB Leerink Outperform Dec 11, 20
Citigroup Buy Feb 12, 20
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
GRAMMER ELIZABETH A See Remarks See Remarks Dec 15 Option 2.32 42,000 97,440 113,527 12/15/20
GRAMMER ELIZABETH A See Remarks See Remarks Dec 15 Sell 7.3 42,000 306,600 72,527 12/15/20